Cite
APA Citation
Reisinger, E. C., Tschismarov, R., Beubler, E., Wiedermann, U., Firbas, C., Loebermann, M., Pfeiffer, A., Muellner, M., Tauber, E., & Ramsauer, K. (2018). immunogenicity, safety, and tolerability of the measles-vectored chikungunya virus vaccine MV-CHIK: a double-blind, randomised, placebo-controlled and active-controlled phase 2 trial. Lancet, 392(10165), 2718–2727. http://access.bl.uk/ark:/81055/vdc_100076119881.0x000053